Title: How accessibility functionality paves the way for increased trial participation
Date: Wednesday, November 15, 2023
Time: 12:00 CET
Valdo will discuss the consequences of the FDA PFDD Guidance 3, the importance of ensuring High Quality Measurements and will present industry-first scientific research to improve the patient experience.
Medical Scientific Advisor and General Manager Geneva Office at Clario
A Medical Doctor by training, Valdo has over 35 years of experience in the pharmaceutical industry. Starting his career as a clinical pharmacologist in a Ciba-Geigy’s daughter company, he then founded the first European Central clinical laboratory dedicated to clinical trials, SciCor (now Labcorp Drug Development). Always passionate about how to improve the clinical trial process, Valdo joined PHT in 2000, and founded the European affiliate of PHT Corporation in January 2001. PHT was acquired by ERT in 2015 and then merged with Bioclinica to form Clario. Valdo has always taken care of the eCOA portion of Clario and is seen as one of the pioneers of the ePRO business.